In recent years, the Ki-67 proliferation index has been widely used to evaluate the proliferation ability of tumor cells, but its prognostic relevance in patients with neuroendocrine differentiation-related gastric cancer is still unclear. This evidence concerns the gene MKI67 and neoplasm.